Breaking News Instant updates and real-time market news.

QTS

QTS Realty Trust

$50.66

-1.17 (-2.26%)

, VMW

VMware

$72.45

-1.16 (-1.58%)

09:02
10/05/16
10/05
09:02
10/05/16
09:02

QTS Realty Trust acquires sole rights to VMware FedRAMP compiant cloud platform

QTS Realty Trust (QTS) announced the acquisition from VMware (VMW) of sole rights to VMware vCloud Government Service, a Federal Risk and Authorization Management Program compliant cloud solution. The vCloud platform, now QTS Government Cloud, is an industry-leading FedRAMP compliant solution that was previously developed in partnership between QTS and VMware to deliver cloud services to the Federal sector. Through this agreement, QTS will now wholly own and control the infrastructure supporting the QTS Government Cloud. Although this is not a material financial transaction, it will provide QTS with expanded flexibility and control in delivering the QTS Government Cloud solution and provide the exclusive rights to sell both directly and through a broader array of sales channels. QTS' comprehensive and growing portfolio of highly compliant hybrid technology solutions is engineered to address IT infrastructure complexity and compliance challenges facing Federal IT professionals in the public sector marketplace.

QTS

QTS Realty Trust

$50.66

-1.17 (-2.26%)

VMW

VMware

$72.45

-1.16 (-1.58%)

  • 26

    Oct

  • 14

    Nov

  • 12

    Dec

QTS QTS Realty Trust
$50.66

-1.17 (-2.26%)

06/07/16
ADAM
06/07/16
INITIATION
Target $63
ADAM
Buy
QTS Realty Trust initiated with a Buy at Canaccord
Canaccord initiated QTS Realty with a Buy rating citing several catalysts, including demand from enterprise and hyperscale cloud service providers, activity in government and healthcare verticals, and EBITDA growth. Canaccord has a $63 price target on QTS Realty shares.
06/24/16
WELS
06/24/16
NO CHANGE
WELS
Data centers have new potential catalysts from cloud growth, says Wells Fargo
Wells Fargo notes that Equinix (EQIX) pointed out new ways that data centers can benefit from the growth of the cloud. Specifically, Equinix noted that data centers can help software-as-a-service providers enable low-latency connections between cloud architectures, Wells Fargo stated. Wells believes that QTS Realty Trust (QTS), CyrusOne (CONE), and Digital Realty (DLR) can all benefit from this trend.
07/05/16
GSCO
07/05/16
INITIATION
Target $57
GSCO
Neutral
QTS Realty Trust initiated with a Neutral at Goldman
Goldman analyst Jiorden Sanchez initiated QTS Realty Trust with a Neutral and $57 price target.
07/21/16
RHCO
07/21/16
INITIATION
Target $55
RHCO
Buy
QTS Realty Trust initiated with a Buy at SunTrust
Target $55.
VMW VMware
$72.45

-1.16 (-1.58%)

09/08/16
09/08/16
UPGRADE
Target $87

Buy
Follow-up: VMware upgraded to Buy at Cleveland Research
As previously reported, Cleveland Research upgraded VMware to Buy from Neutral and sees upside to $87. The firm's analyst is encouraged by vSAN and NSX performance in 2H 2016 and into 2017, less worse declines of vSphere, and increased confidence in potential contributions from the Dell relationship. Cleveland has increased our bookings and FCF assumptions into FY17 to reflect the optimistic feedback from channel partners.
09/12/16
RBCM
09/12/16
INITIATION
RBCM
Outperform
VMware reinstated with an Outperform at RBC Capital
RBC Capital analyst Matthew Hedberg thinks that VMware's results can beat lowered expectations, driven by its new products. Hedberg says that the stock's risk/reward ratio is favorable relative to its peers following the decline in the shares. He set an $88 price target on the shares.
09/13/16
LEHM
09/13/16
INITIATION
Target $82
LEHM
Equal Weight
VMware reinstated with an Equal Weight at Barclays
Barclays analyst Raimo Lenschow reinstated VMware with an Equal Weight rating and $82 price target.
10/04/16
OTRG
10/04/16
NO CHANGE
OTRG
VMware channel business read remains negative, says OTR Global
OTR Global's VMware partner channel checks remain negative with Q3 sales goals below plan at a majority surveyed. The firm's analyst said interest in NSX and other advanced solutions is building but revenue from new products is not enough to offset the slowdown in the core virtualization business, and direct sales interference is hurting channel partners ability to close deals.

TODAY'S FREE FLY STORIES

AXS

AXIS Capital

$63.32

0.42 (0.67%)

08:31
12/09/16
12/09
08:31
12/09/16
08:31
Hot Stocks
AXIS Capital announces new $1B share repurchase authorization »

AXIS Capital announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMTD

TD Ameritrade

$43.22

0.51 (1.19%)

08:31
12/09/16
12/09
08:31
12/09/16
08:31
Hot Stocks
TD Ameritrade reports November client trades per day up 23% y/y »

TD Ameritrade announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$28.97

-0.83 (-2.79%)

, NTLA

Intellia Therapeutics

$15.38

0.06 (0.39%)

08:30
12/09/16
12/09
08:30
12/09/16
08:30
Options
Two new option listings and three option delistings on December 9th »

New option listings for…

ACRS

Aclaris Therapeutics

$28.97

-0.83 (-2.79%)

NTLA

Intellia Therapeutics

$15.38

0.06 (0.39%)

LGF

Lionsgate

$26.09

1.1 (4.40%)

LNKD

LinkedIn

STRZA

Starz

$35.52

0.59 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$12.33

-0.3 (-2.38%)

08:30
12/09/16
12/09
08:30
12/09/16
08:30
Conference/Events
Pure Storage participates in a conference call with UBS »

UBS IT Hardware & EMS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 12

    Dec

  • 12

    Jan

  • 13

    Jan

  • 09

    Dec

08:30
12/09/16
12/09
08:30
12/09/16
08:30
General news
U.S. equities are back in the green »

U.S. equities are back in…

SGYP

Synergy Pharmaceuticals

$5.54

0.06 (1.09%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Hot Stocks
Breaking Hot Stocks news story on Synergy Pharmaceuticals »

Synergy Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

LFUS

Littelfuse

$154.58

3.1 (2.05%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Littelfuse to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WWD

Woodward

$70.84

-0.26 (-0.37%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Wayfair Woodward to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DVAX

Dynavax

$4.80

-0.2 (-4.00%)

08:25
12/09/16
12/09
08:25
12/09/16
08:25
Conference/Events
Dynavax to host research and development day »

Cancer Research and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 15

    Dec

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

08:24
12/09/16
12/09
08:24
12/09/16
08:24
Downgrade
Duluth Holdings rating change  »

Duluth Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBAI

Lakeland Bancorp

$19.15

0.3 (1.59%)

08:24
12/09/16
12/09
08:24
12/09/16
08:24
Syndicate
Breaking Syndicate news story on Lakeland Bancorp »

Lakeland Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLSD

Clearside Biomedical

$11.53

-2.9 (-20.10%)

08:23
12/09/16
12/09
08:23
12/09/16
08:23
Syndicate
Clearside Biomedical 4M share Secondary priced at $9.00 »

JPMorgan, Cowen and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

BIIB

Biogen

$289.54

4.24 (1.49%)

, LLY

Eli Lilly

$67.19

-0.19 (-0.28%)

08:21
12/09/16
12/09
08:21
12/09/16
08:21
Recommendations
Biogen, Eli Lilly analyst commentary  »

Biogen has positive read…

BIIB

Biogen

$289.54

4.24 (1.49%)

LLY

Eli Lilly

$67.19

-0.19 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

08:20
12/09/16
12/09
08:20
12/09/16
08:20
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

FNSR

Finisar

$34.13

1.89 (5.86%)

08:17
12/09/16
12/09
08:17
12/09/16
08:17
Recommendations
Finisar analyst commentary  »

Finisar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZBRA

Zebra Technologies

$83.39

0.47 (0.57%)

08:15
12/09/16
12/09
08:15
12/09/16
08:15
Recommendations
Zebra Technologies analyst commentary  »

Zebra Technologies prie…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$170.71

2.16 (1.28%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Recommendations
Broadcom analyst commentary  »

Broadcom poised for above…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCBJY

UCB Pharma

$30.84

-1.11 (-3.47%)

, MYL

Mylan

$36.06

1.56 (4.52%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Periodicals
UCB Pharma Vimpat patent 'thrown out' by patent office, Bronte Capital reports »

Argentum…

UCBJY

UCB Pharma

$30.84

-1.11 (-3.47%)

MYL

Mylan

$36.06

1.56 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

HLT

Hilton

$26.24

-0.8 (-2.96%)

08:14
12/09/16
12/09
08:14
12/09/16
08:14
Downgrade
Hilton rating change  »

Hilton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CDEV

Centennial Resource Development

$18.29

-0.32 (-1.72%)

08:12
12/09/16
12/09
08:12
12/09/16
08:12
Initiation
Centennial Resource Development initiated  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTEA

Long Island Iced Tea

$4.91

0.2 (4.25%)

08:12
12/09/16
12/09
08:12
12/09/16
08:12
Hot Stocks
Long Island Iced Tea agrees to acquire ALO Juice »

Long Island Iced Tea…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCON

Superconductor Technologies

$2.02

-0.13 (-6.05%)

08:11
12/09/16
12/09
08:11
12/09/16
08:11
Syndicate
Superconductor Technologies raises $10.2M in a public offering »

The offering was priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBMG

Cellular Biomedicine

$13.35

0.1 (0.75%)

08:09
12/09/16
12/09
08:09
12/09/16
08:09
Hot Stocks
Cellular Biomedicine announces 3-month interim safety data from AlloJoin trial »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EW

Edwards Lifesciences

$89.30

5.57 (6.65%)

08:09
12/09/16
12/09
08:09
12/09/16
08:09
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIRG

Airgain

$18.62

-2.13 (-10.27%)

08:08
12/09/16
12/09
08:08
12/09/16
08:08
Syndicate
Airgain 2.35M share Secondary priced at $17.00 »

Cowen, William Blair and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.